NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been invited to participate in a panel discussion on nanomedicines development at the NanoBusiness2010.
This event is taking place today at 2pm CDT at the 9th annual NanoBusiness Conference, held at the McCormick Place in Chicago, IL.
The panel, entitled “NanoMedicine: Science, Business and Regulatory Perspectives,” is composed of experts from Industry, Government, and Academia. It is chaired and moderated by Dr. Mostafa Analoui, Head of HealthCare and Life Sciences at the Livingston Securities, NY. Dr. Diwan will discuss the current developments at NanoViricides, Inc., and the opportunities and challenges in bringing our nanoviricide® drugs to market.